Related Experiment Video
Updated: May 14, 2026

Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
Rapid accelerated hemodialysis in children with end-stage renal disease: a randomized clinical trial
Mohamed Khaled El Hatw1, Fatina Fadel, Ramzy El Baroudy
1Cairo University Children's Hospital, Cairo, Egypt. melhatw@yahoo.com
Insights
Rapid accelerated hemodialysis with recirculation (R-AHD PR) allows for reduced heparin use in pediatric patients undergoing dialysis. However, this method did not improve overall dialysis efficiency compared to standard treatments.
Area of Science:
- Nephrology
- Pediatric Dialysis
- Cardiovascular Engineering
Background:
- Rapid Accelerated Hemodialysis (R-AHD) is a technique designed to increase blood flow rate (BFR) through partial recirculation.
- R-AHD PR utilizes two blood pump segments to manage recirculation, aiming to enhance anticoagulation and dialysis efficiency.
- Pediatric end-stage renal disease patients require effective and safe dialysis strategies, particularly concerning anticoagulation.
Purpose of the Study:
- To evaluate the effectiveness of R-AHD PR in improving anticoagulation and dialysis efficiency in children with end-stage renal disease.
- To assess the feasibility of using reduced or no heparin with R-AHD PR.
- To compare R-AHD PR outcomes with conventional double needle hemodialysis (DNHD).
Main Methods:
- A two-stage study involving ten pediatric patients with end-stage renal disease.
- Stage 1: Assessed various R-AHD protocols with different heparin doses, followed by a control period of DNHD.
- Stage 2: Compared R-AHD PR with DNHD, including protocols with low-dose and no heparin, monitoring blood clotting and urea reduction rates.
Main Results:
- Blood clots occurred in 4 out of 165 R-AHD sessions but in none of the 28 R-AHD PR sessions.
- Mean urea reduction rates in Stage 1 were comparable between R-AHD protocols (0.60-0.70) and control DNHD (0.71).
- In Stage 2, R-AHD PR showed a trend towards lower urea reduction (0.66 ± 0.15) compared to DNHD (0.79 ± 0.18), though not statistically significant (P=0.059).
Conclusions:
- R-AHD PR enables successful hemodialysis in children using low or no heparin without increasing patient blood flow rate.
- The R-AHD PR technique did not demonstrate an improvement in dialysis efficiency compared to standard DNHD.
- R-AHD PR shows promise for reduced anticoagulation in pediatric hemodialysis, warranting further investigation into its efficiency.
Abstract:
In rapid accelerated hemodialysis (R-AHD), blood partially recirculates from the venous (outflow) to the arterial (inflow) line through a recirculation line (R) to selectively increase the filter blood flow rate (BFR). R-AHD PR uses two blood pump segments at the patient segment of the arterial line and at (R). To determine the effectiveness of R-AHD with regard to increasing anticoagulation and dialysis efficiency, we studied ten children with end-stage renal disease in two stages: stage 1 with 10 routine heparin R-AHD, then 10 half-dose heparin R-AHD, then 145 routine heparin R-AHD sessions for 1 month and then routine heparin double needle hemodialysis (DNHD) for one month (control). In stage 2, we dialyzed the patients with 10 routine heparin-mixed AHD PR and DNHD sessions, then eight low-dose heparin R-AHD PR" sessions, then one of the children with 10 no-heparin R-AHD PR sessions and then 10 routine heparin DNHD sessions" (control). Signs of blood clotting and dialysis efficiency were monitored. Blood clots appeared in four out of 165 R-AHD 0 (one pump circuit) sessions but in none of the 28 R-AHD PR sessions. In stage 1, the mean urea reduction rate was 0.60, 0.60 and 0.70 for the R-AHD protocols, compared with 0.71 for the control (P >0.05). In stage 2, the arterial blood urea nitrogen was reduced by 0.66 ± 0.15 after an R-AHD PR period, compared with 0.79 ± 0.18 after a DNHD period (P = 0.059). In conclusion, R-AHD PR allowed successful low heparin and no heparin hemodialysis in children without increasing the patients' BFR. However, the technique did not increase the efficiency of dialysis.
Related Concept Videos
Hemodialysis I: Introduction
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications
Acute Kidney Injury V: Interprofessional Care
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy